13F Holdings
中文EN

PODD INSULET CORP

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1145197 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY26.5%
TTM net income YoY74.2%
TTM EPS YoY78.4%
Revenue 3-yr CAGR27.0%
Net income 3-yr CAGR52.9%

Margins

Gross margin71.9%
Operating margin18.4%
Net margin13.4%
FCF margin8.2%
EBITDA margin21.7%

Returns

ROE28.9%
ROA13.3%
ROIC (approx.)25.5%
Asset turnover0.99x

Leverage & solvency

Liabilities / assets53.8%
Debt / equity0.61x
Current ratio2.51x
Interest coverage9.91x

Cash quality & payout

Operating cash flow / net income1.19x
Accruals ratio-2.5%
Payout ratio—
Capex / revenue7.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$2.71B$2.07B$1.70B$1.31B$1.10B
Cost of revenue$768.20M$625.90M$537.20M$499.70M$346.70M
Gross profit$1.94B$1.45B$1.16B$805.60M$752.10M
R&D expense$301.10M$219.60M$205.00M$180.20M$160.10M
SG&A expense$1.17B$917.20M$734.80M$587.80M$466.00M
Operating income$473.80M$308.90M$220.10M$37.60M$126.00M
Interest expense$59.40M$42.70M$36.20M$36.00M$61.70M
Pretax income$339.50M$300.20M$214.70M$9.80M$20.50M
Income tax$92.40M-$118.10M$8.30M$5.20M$3.70M
Net income$247.10M$418.30M$206.30M$4.60M$16.80M
EBITDA$564.20M$389.70M$292.90M$100.80M$183.40M
EPS (basic)3.515.972.960.070.25
EPS (diluted)3.485.782.940.070.24
Weighted avg. shares (diluted)71.89M73.89M73.63M69.91M68.58M
Banking
Net interest income———-$26.70M-$61.20M
Balance sheet
Cash & equivalents$716.10M$953.40M$704.20M$689.80M$806.40M
Short-term investments————$0
Receivables$516.90M——$140.90M$135.20M
Inventory$452.60M$430.40M$402.60M$346.80M$303.20M
Current assets$1.91B$1.89B$1.58B$1.31B$1.33B
PP&E, net$819.50M$723.10M$664.90M$599.90M$536.50M
Goodwill$51.60M$51.50M$51.70M$51.70M$39.80M
Intangibles$117.10M$98.50M$98.70M$75.50M$36.60M
Total assets$3.19B$3.09B$2.59B$2.25B$2.05B
Current liabilities$680.10M$528.40M$451.20M$364.70M$228.80M
Short-term debt$18.40M$83.80M$49.40M$27.50M$25.10M
Long-term debt$930.80M$1.30B$1.37B$1.37B$1.25B
Total debt$949.20M$1.38B$1.42B$1.40B$1.27B
Total liabilities$1.68B$1.88B$1.86B$1.77B$1.49B
Shareholders' equity$1.52B$1.21B$732.70M$476.40M$556.30M
Net debt$233.10M$426.50M$711.60M$712.00M$467.50M
Shares outstanding70.39M70.20M69.91M69.51M69.18M
Cash flow statement
Operating cash flow$569.30M$430.20M$145.70M$119.00M-$68.10M
Capital expenditure$191.60M$124.90M$75.60M$122.90M$111.90M
Free cash flow$377.70M$305.30M$70.10M-$3.90M-$180.00M
Investing cash flow-$222.70M-$146.20M-$119.40M-$191.10M-$82.70M
Financing cash flow-$595.30M-$28.00M-$13.60M-$40.30M$40.70M
Depreciation & amortization$90.40M$80.80M$72.80M$63.20M$57.40M
Stock-based compensation$62.70M$69.30M$48.40M$40.90M$34.40M
Share buybacks$59.60M$0$0——

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.